No abstract available
MeSH terms
-
Adenocarcinoma / mortality*
-
Adenocarcinoma / secondary
-
Adenocarcinoma / therapy*
-
Aged
-
Antimetabolites, Antineoplastic / administration & dosage*
-
Brachytherapy / methods
-
Brachytherapy / mortality
-
Chemoradiotherapy / methods*
-
Chemoradiotherapy / mortality
-
Disease Progression
-
Drug Administration Schedule
-
Female
-
Humans
-
Male
-
Middle Aged
-
Prevalence
-
Radiation Dose Hypofractionation
-
Rectal Neoplasms / mortality
-
Rectal Neoplasms / pathology
-
Rectal Neoplasms / therapy*
-
Risk Factors
-
Survival Rate
-
Treatment Outcome
-
Watchful Waiting / methods*
Substances
-
Antimetabolites, Antineoplastic